{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:07Z","timestamp":1761630367431,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":6308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.exphem.2004.12.003","type":"journal-article","created":{"date-parts":[[2005,2,23]],"date-time":"2005-02-23T07:14:19Z","timestamp":1109142859000},"page":"380-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Christina","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Forsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuchehr","family":"Abedi-Valugerdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmel","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hernan","family":"Concha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustapha","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2004.12.003_bib1","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V98.13.3569","article-title":"Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies","volume":"98","author":"Socie","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2004.12.003_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF02906128","article-title":"The role of busulfan in bone marrow transplantation","volume":"16","author":"Hassan","year":"1999","journal-title":"Med Oncol"},{"key":"10.1016\/j.exphem.2004.12.003_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bmt.1700994","article-title":"High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients","volume":"20","author":"Ljungman","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00686213","article-title":"Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics","volume":"33","author":"Hassan","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.exphem.2004.12.003_bib5","first-page":"2083","article-title":"Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)","volume":"16","author":"Buggia","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1016\/j.exphem.2004.12.003_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00007691-200008000-00003","article-title":"Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy","volume":"22","author":"Hassan","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.exphem.2004.12.003_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bmt.1703896","article-title":"The effect of metronidazole on busulfan pharmacokinetics in patients undergoing stem cell transplantation","volume":"31","author":"Nilsson","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-112-11-881_1","article-title":"Busulfan and veno-occlusive disease of the liver","volume":"112","author":"Vassal","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.exphem.2004.12.003_bib9","first-page":"869","article-title":"Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants","volume":"15","author":"Ljungman","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00002820-199812000-00002","article-title":"Acute oral pain and mucositis in bone marrow transplant and leukemia patients: data from a pilot study","volume":"21","author":"McGuire","year":"1998","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.exphem.2004.12.003_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00686397","article-title":"In vivo distribution of [11C]-busulfan in cynomolgus monkey and in brain of human patient","volume":"30","author":"Hassan","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.exphem.2004.12.003_bib12","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood.V84.7.2144.2144","article-title":"Busulfan bioavailability","volume":"84","author":"Hassan","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2004.12.003_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.1996.d01-1681.x","article-title":"A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia","volume":"93","author":"Ringden","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2004.12.003_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2165\/00003088-199120030-00002","article-title":"Clinical pharmacokinetic of cyclophosphamide","volume":"20","author":"Moore","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.exphem.2004.12.003_bib15","first-page":"1331","article-title":"Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome py50 gene","volume":"56","author":"Chen","year":"1996","journal-title":"Cancer Res."},{"issue":"suppl 3","key":"10.1016\/j.exphem.2004.12.003_bib16","first-page":"S13","article-title":"The cytokine modulation of acute graft-vesus-host disease","volume":"21","author":"Ferrara","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s002800050847","article-title":"Pharmacokinetics and distribution of liposomal busulfan in the rat: a new formulation for intravenous administration","volume":"42","author":"Hassan","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.exphem.2004.12.003_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0378-4347(00)84861-6","article-title":"Gas chromatographic determination of busulfan in plasma with electron-capture detection","volume":"277","author":"Hassan","year":"1983","journal-title":"J Chromatogr"},{"key":"10.1016\/j.exphem.2004.12.003_bib19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1701458","article-title":"Liposomal busulphan: bioavailability and effect on bone marrow in mice","volume":"22","author":"Hassan","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib20","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.exphem.2003.09.008","article-title":"Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?","volume":"31","author":"Ferry","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2004.12.003_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bmt.1703612","article-title":"Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation","volume":"30","author":"McCune","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bmt.1702377","article-title":"The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity","volume":"25","author":"Hassan","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/intimm\/5.6.565","article-title":"Critical role of interleukin-2 in the development of acute graft-versus-host disease","volume":"5","author":"Via","year":"1993","journal-title":"Int Immunol"},{"key":"10.1016\/j.exphem.2004.12.003_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4049\/jimmunol.164.2.656","article-title":"The p55 TNF-alpha receptor plays a critical role in the T cell alloreactivity","volume":"164","author":"Hill","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2004.12.003_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1083-8791(03)00087-9","article-title":"Role of tumor necrosis factor-alpha in graft-versus-host-disease and graft-versus-leukemia responses","volume":"9","author":"Korngold","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0268-960X(03)00009-2","article-title":"Immunobiology of acute graft-versus-host disease","volume":"17","author":"Reddy","year":"2003","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2004.12.003_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00007890-198309000-00011","article-title":"Lethal murine graft-versus-host disease in the absence of detectable cytotoxic T lymphocytes","volume":"36","author":"Jadus","year":"1983","journal-title":"Transplantation"},{"key":"10.1016\/j.exphem.2004.12.003_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0301-472X(00)00677-9","article-title":"Acute graft-vs-host disease: pathobiology and management","volume":"29","author":"Goker","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2004.12.003_bib29","first-page":"18","article-title":"Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction","volume":"68","author":"Mowat","year":"1989","journal-title":"Immunology"},{"key":"10.1016\/j.exphem.2004.12.003_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1365-2567.2003.01663.x","article-title":"The role of interferon-gamma, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice","volume":"109","author":"Ellison","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.exphem.2004.12.003_bib31","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.4049\/jimmunol.151.11.6451","article-title":"Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice","volume":"151","author":"Brok","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2004.12.003_bib32","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1073\/pnas.87.15.5633","article-title":"Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells","volume":"87","author":"Sykes","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2004.12.003_bib33","first-page":"135","article-title":"Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children","volume":"10","author":"Meresse","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib34","first-page":"225","article-title":"Association of busulfan area under the curve with veno-occlusive disease following BMT","volume":"17","author":"Dix","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2004.12.003_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000028359","article-title":"Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes","volume":"60","author":"DeLeve","year":"2000","journal-title":"Pharmacology"},{"key":"10.1016\/j.exphem.2004.12.003_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.bmt.1704143","article-title":"N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation","volume":"32","author":"Sj\u00f6\u00f6","year":"2003","journal-title":"Bone Marrow Transplant"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X04004436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X04004436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:19:09Z","timestamp":1759565949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X04004436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0301472X04004436"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2004.12.003","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2004.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}